Enliven Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 08/13/2026 | 10.03 M | $508.77 M | 46.80% | 15.15% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 6.78 M | $343.91 M | -14.86% | 10.24% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2026 | 6.43 M | $326.35 M | 26.94% | 9.72% |
| BLACKROCK, INC. | 08/07/2026 | 4.36 M | $221.25 M | 18.32% | 6.59% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 4.00 M | $203.00 M | 23.08% | 6.04% |
| COMMODORE CAPITAL LP | 08/14/2026 | 3.28 M | $166.21 M | 0.00% | 4.95% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 2.90 M | $147.37 M | 2,870.84% | 4.39% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 2.57 M | $130.38 M | 18.49% | 3.88% |
| CITADEL ADVISORS LLC | 09/02/2026 | 2.07 M | $105.00 M | 18.64% | 3.13% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 08/14/2026 | 1.86 M | $94.17 M | 0.00% | 2.80% |
| SIREN, L.L.C. | 08/13/2026 | 1.77 M | $90.05 M | 137.78% | 2.68% |
| BELLEVUE GROUP AG | 08/14/2026 | 1.49 M | $75.62 M | -35.80% | 2.25% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.41 M | $71.43 M | 31.96% | 2.13% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 08/14/2026 | 1.36 M | $69.06 M | 574.08% | 2.06% |
| STATE STREET CORP | 09/22/2026 | 1.21 M | $61.59 M | 11.23% | 1.93% |
| PICTET ASSET MANAGEMENT HOLDING SA | 07/30/2026 | 1.16 M | $58.96 M | 24.98% | 1.76% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 1.08 M | $54.98 M | 100.00% | 1.64% |
| NOVO HOLDINGS A/S | 08/14/2026 | 1.00 M | $50.75 M | -21.88% | 1.51% |
| FIRST TURN MANAGEMENT, LLC | 08/14/2026 | 954.36 K | $48.43 M | 52.98% | 1.44% |
| SAMLYN CAPITAL, LLC | 08/14/2026 | 912.64 K | $46.32 M | 100.00% | 1.38% |
| CANDRIAM S.C.A. | 08/13/2026 | 905.67 K | $45.92 M | 52.45% | 1.37% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 905.19 K | $45.94 M | 0.00% | 1.37% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 896.16 K | $35.13 M | 16.10% | 1.35% |
| TRI LOCUM PARTNERS LP | 08/14/2026 | 866.72 K | $43.99 M | 100.00% | 1.31% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 671.41 K | $34.07 M | -1.51% | 1.01% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 607.19 K | $30.81 M | 95.85% | 0.92% |
| JUPITER TOPCO LLC | 08/14/2026 | 604.12 K | $30.62 M | 100.00% | 0.91% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2026 | 566.17 K | $28.73 M | 811.46% | 0.86% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 562.76 K | $28.56 M | 70.04% | 0.85% |
| AVIDITY PARTNERS MANAGEMENT LP | 08/14/2026 | 550.00 K | $27.91 M | 37.50% | 0.83% |
| MARSHALL WACE, LLP | 08/13/2026 | 532.27 K | $27.01 M | 100.00% | 0.80% |
| VR ADVISER, LLC | 08/14/2026 | 526.33 K | $26.71 M | -69.51% | 0.80% |
| MORGAN STANLEY | 08/13/2026 | 509.93 K | $25.88 M | -1.67% | 0.77% |
| AFFINITY ASSET ADVISORS, LLC | 08/13/2026 | 500.00 K | $25.38 M | -14.81% | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/13/2026 | 489.38 K | $24.84 M | 100.00% | 0.74% |
| LOGOS GLOBAL MANAGEMENT LP | 08/14/2026 | 465.00 K | $23.60 M | -13.89% | 0.70% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2026 | 464.63 K | $23.58 M | -43.78% | 0.70% |
| NORTHERN TRUST CORP | 08/13/2026 | 440.94 K | $22.38 M | 18.43% | 0.67% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 424.44 K | $21.54 M | 17.71% | 0.64% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 424.44 K | $21.54 M | 100.00% | 0.64% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 411.36 K | $20.88 M | 19.13% | 0.62% |
| NICHOLAS INVESTMENT PARTNERS, LP | 08/14/2026 | 391.53 K | $19.87 M | 114.27% | 0.59% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 387.72 K | $19.68 M | 17.65% | 0.59% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 383.49 K | $19.46 M | 22.61% | 0.58% |
| NUVEEN, LLC | 08/11/2026 | 374.22 K | $18.99 M | 253.43% | 0.57% |
| SEVEN FLEET CAPITAL MANAGEMENT LP | 08/17/2026 | 365.39 K | $18.54 M | 122.76% | 0.55% |
| WOODLINE PARTNERS LP | 08/14/2026 | 347.14 K | $17.62 M | 15.07% | 0.52% |
| STEMPOINT CAPITAL LP | 08/14/2026 | 346.91 K | $17.61 M | -4.55% | 0.52% |
| UBS GROUP AG | 08/13/2026 | 342.12 K | $17.36 M | 20.66% | 0.52% |
| LORD, ABBETT & CO. LLC | 08/14/2026 | 330.76 K | $16.79 M | 100.00% | 0.50% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enliven Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 251 institutional investors and hedge funds held shares of Enliven Therapeutics Inc. The most heavily invested institutionals were:
Versant Capital Management, Inc: 1,613
Farther Finance Advisors, LLC: 780
GAMMA Investing LLC: 447
MASSMUTUAL TRUST CO FSB/ADV: 197
FMR LLC: 10.03 M
ORBIMED ADVISORS LLC: 6.78 M
121.88% of Enliven Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 87.02 M shares in the last 24 months. This purchase volume represents approximately $2.59 B in transactions.